Time is running out for people in the prescription drug business who want to have a say in how their products are marketed and advertised over the Internet. The Food and Drug Administration is developing a policy addressing the increasingly sticky issue of marketing prescription drugs and other medical products on the World Wide Web.
The FDA's cutoff for written comments is Dec. 16, after which the agency will begin establishing guidelines that are likely to place tighter restrictions on what may and may not be promoted on line. (FDA, 301/443-3170)
Subscribe to PRNEWS for unlimited access to all digital intelligence, exclusive reports and more. Learn More.
CRISIS INSIDER
Access to all Crisis Insider articles, quarterly reports and valuable blueprints for crisis management.
$29
Per Month Lowest Price
PLATINUM
Best Value!
Unlimited access to all Premium and Crisis Insider articles and monthly reports.
First Year Offer
$68
Per Month
Already a subscriber?